Clinical trial
Retinal and RPE Autoimmunity in AMD: Assessment of Correlation With Degree of Response to Ranibizumab Therapy
NCT00931489 is registered in ClinicalTrials.gov with Lawrence S. Morse, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retinal and RPE Autoimmunity in AMD: Assessment of Correlation With Degree of Response to Ranibizumab Therapy
- Lead sponsor
- Lawrence S. Morse, MD
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2009
- Completion date
- June 30, 2014
- Enrollment
- 131 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
age related macular degeneration